Scarica l'app Stockscreener
18.44
1.55%
-0.29
Dopo l'orario di chiusura:
18.44
Ceribell Inc Borsa (CBLL) Ultime notizie
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target - MarketScreener
Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s (NASDAQ:CBLL) Lock-Up Period To Expire on April 9th - Defense World
Critical Comparison: CeriBell (NASDAQ:CBLL) and InMode (NASDAQ:INMD) - Defense World
Charles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL) - Defense World
Bank of New York Mellon Corp Purchases New Holdings in CeriBell (NASDAQ:CBLL) - Defense World
PNC Financial Services Group Inc. Invests $47,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Announces Executive Compensation Adjustments - TipRanks
Ceribell executives receive pay increases and incentives By Investing.com - Investing.com Australia
Ceribell executives receive pay increases and incentives - Investing.com
Brokerages Set CeriBell (NASDAQ:CBLL) Price Target at $32.60 - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average PT from Analysts - Defense World
Rhumbline Advisers Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s Earnings Call: Strong Growth Amid Challenges - TipRanks
William Blair Has Negative Estimate for CeriBell Q1 Earnings - Armenian Reporter
William Blair Estimates CeriBell’s Q1 Earnings (NASDAQ:CBLL) - Defense World
Canaccord Genuity Group Reaffirms Buy Rating for CeriBell (NASDAQ:CBLL) - Defense World
Ceribell revenue increases 41% to USD 18.5M in Q4 2024 - Medical Buyer
CeriBell, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Ceribell, Inc.: Strong Financial Performance and Strategic Investments Justify Buy Rating - TipRanks
Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating for Ceribell, Inc. - TipRanks
Ceribell, Inc. Reports Strong 2024 Financial Growth - TipRanks
Ceribell, Inc.: Strong Financial Performance and Growth Potential Drive Buy Rating - TipRanks
Earnings call transcript: CeriBell Q4 2024 shows 41% revenue growth - Investing.com
Earnings call transcript: CeriBell Q4 2024 shows 41% revenue growth By Investing.com - Investing.com UK
CeriBell Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ceribell, Inc. Reports Significant Revenue Growth in Fourth Quarter and Full Year 2024 Financial Results - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
CeriBell: A Leader In AI-Powered Seizure Detection (NASDAQ:CBLL) - Seeking Alpha
CeriBell (CBLL) to Release Earnings on Tuesday - MarketBeat
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference - The Manila Times
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Target Price from Analysts - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Price Target from Brokerages - Defense World
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - The Manila Times
CeriBell, Inc. to Announce Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
CeriBell (CBLL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
CeriBell (CBLL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Hospitals adopt AI tech to improve seizure detection in Humboldt County - KRCR
Top 145+ startups in Smart EEG Devices in Jan, 2025 - Tracxn
Nexalin Technology (NASDAQ:NXL) vs. CeriBell (NASDAQ:CBLL) Head-To-Head Contrast - Defense World
CeriBell (NASDAQ:CBLL) Trading 9.1% HigherShould You Buy? - MarketBeat
Beta Bionics targets up to $616 mln valuation in US IPO - Reuters
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus Price Target from Analysts - Defense World
Ceribell Expands its Executive Management Team by Two - MPO-mag
CeriBell (NASDAQ:CBLL) Hits New 52-Week LowTime to Sell? - MarketBeat
7.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):